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1176Objective: Recent developments in adjunctive therapy have enabled us to remove once-implanted left ventric-
ular assist devices. For successful device removal, appropriate patient selection and precise evaluation of cardiac
function are essential. However, with rotary pumps, pump weaning inevitably creates diastolic retrograde pump
flow, and this flow may overload the native heart. We developed a novel ‘‘off-test mode’’ for weaning, which
increases revolutions per minute just in diastole. The present study evaluated the effect of this mode on retro-
grade pump flow and ventricular workload.
Methods: The EVAHEART device (Sun Medical Technology Research Corporation, Nagano, Japan) was in-
stalled in 8 goats (63.0  7.3 kg). We evaluated myocardial oxygen consumption, pressure volume area, and
retrograde pump flow under 3 conditions: circuit clamp, continuous mode, and off-test mode. In continuous
mode, revolution per minute was set for a mean net pump flow of zero, whereas in off-test mode, systolic rev-
olution per minute was kept at a minimum level and diastolic revolution per minute was adjusted to ensure near-
zero diastolic retrograde pump flow.
Results: In off-test mode, the pressure volume loop shapes were similar to those under circuit-clamp conditions,
with both myocardial oxygen consumption and pressure volume area approximately equal to those under clamp
conditions. Retrograde pump flow was significantly decreased in off-test compared with continuous mode
(P ¼ .005).
Conclusions:Off-test mode decreased retrograde flow during weaning while keeping ventricular workload sim-
ilar to baseline. This mode is potentially valuable for establishing a safe and appropriate pump weaning protocol
after myocardial recovery. Investigations on heart failure models are ongoing. (J Thorac Cardiovasc Surg
2012;143:1176-82)Rotary left ventricular assist devices (LVADs) have greatly
improved the outcomes of patients with end-stage heart fail-
ure,1,2 and recent developments in adjunctive therapy have
enabled us to remove once-implanted LVADs from more
patients than before.3-5 In the near future, new options,
such as stem cell induction6 or gene therapy,7 should accel-
erate myocardial recovery and may further increase the rate
of successful LVAD withdrawal.
However, to avoid removal failure, appropriate patient se-
lection and precise evaluation of native heart function are es-
sential.4,8,9 With pulsatile pumps, which occasionally have
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The Journal of Thoracic and Cardiovascular Surprevent retrograde pump flow (PF), we can clamp the
circuits or stop the driving pumps and evaluate cardiac
function without support.10 The judgment should be made
promptly, because no PF in the pulsatile system correlates
with a high risk of thrombus formation.8With rotary pumps,
which are widely used at present,11 circuit clamping is vir-
tually impossible, and taking down pumps inevitably creates
a degree of retrograde PF in the diastolic phase, when pres-
sure head (ie, aortic pressure [AoP] left ventricular [LV]
pressure) becomes relatively high. Among the rotary
LVADs, axial-flow pumps produce minimal retrograde PF,
such that they can be stopped or briefly driven at a low num-
ber of revolutions perminute (RPM), allowing a removal de-
cision to bemade.4,11 However, with centrifugal pumps, this
decision can be made only by gradually decreasing RPM
and carefully establishing low-flow conditions. A mean PF
of zero can result in overloading of the native heart and, in
the worst case, aggravate its function.12 Schima and col-
leagues10 reported that an assist flow of 1.0 to 1.5 L/min re-
quires work equivalent to that of the unsupported heart in
a computer model analysis. However, this condition defi-
nitely differs among pump systems, and the optimal wean-
ing protocol for rotary pumps has yet to be established.gery c May 2012
Abbreviations and Acronyms
AoF ¼ aortic flow
AoP ¼ aortic pressure
CVP ¼ central venous pressure
ECG ¼ electrocardiography
EDP ¼ end-diastolic pressure
EDV ¼ end-diastolic volume
ESV ¼ end-systolic volume
LV ¼ left ventricular
LVAD ¼ left ventricular assist device
MVO2 ¼ myocardial oxygen consumption
PF ¼ pump flow
PV ¼ pressure volume
PVA ¼ pressure volume area
RPM ¼ revolutions per minute
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pumps that can change its RPM in synchronization with
heart beats. If we can increase RPM just in diastole, we
may be able to control this backward flow. This novel sys-
tem may help to create the ideal ‘‘off-test mode’’ for
a safe and appropriate LVAD weaning protocol. The ideal
off-test mode we are suggesting achieves both minimal sup-
port in the systolic phase and no forward or backward flow
in the diastolic phase. In other words, ‘‘zero-total-flow’’ is
created as if circuits are clamped, while keeping the circuits
open and pumps driving. We previously reported the effects
of this mode on retrograde PF during weaning in mock sys-
tems.12,13 In our experiments, the off-test mode effectively
decreased intracircuit retrograde flow in mock circulatory
systems. The present study was designed to test this novel
system of centrifugal pumps in acute animal models and
to evaluate the effects of this mode on retrograde PF and
LV workload, or myocardial oxygen consumption
(MVO2) and pressure volume area (PVA).
MATERIALS AND METHODS
Experimental Preparation
Experiments were performed on 8 goats (63.0  7.3 kg) sedated with
an intramuscular injection of ketamine (10 mg/kg). General anesthesia
was maintained by inhalation of isoflurane. The animals were fixed in
the right recumbent position and mechanically ventilated. Inhaled oxygen
was controlled to achieve a target arterial oxygen pressure of 100 to 150
mm Hg. The heart was approached via a left thoracotomy, and pressure
lines for AoP and central venous pressure (CVP) monitoring were estab-
lished from the left internal thoracic artery and vein. We placed an 18-mm
electromagnetic flow probe (EMF-1000, Nihon Kohden, Tokyo, Japan) on
the ascending aorta for ascending aortic flow (AoF) monitoring and
a 3-mm ultrasonic flow probe (HQD3FSB, Transonic Systems Inc, New
York, NY) on the main trunk of the left coronary artery for coronary
flow monitoring. A 16-mm outflow cannula was sutured to the descending
aorta, and a 16-mm ultrasonic flow probe (TS420, Transonic Systems Inc)
was placed around the outflow cannula for PF monitoring. After heparin-
ization (300 U/kg), the LV apex was removed with a 19-mm puncher, andThe Journal of Thoracic and Cara 20-mm inflow cannula was inserted. Both outflow and inflow cannulae
were connected to the EVAHEART device (Sun Medical Technology
Research Corporation, Nagano, Japan),14 and left heart bypass was
started. A 4F Mikro-Tip catheter pressure transducer (Millar Instruments,
Houston, Tex) and 6F conductance catheter (2S-RH-6DA-116, 6F, 6 mm,
Taisho Biomed Instrument Co, Ltd, Osaka, Japan) were inserted from the
anterior wall of the LV for pressure volume (PV) loop monitoring. The
inferior vena cava was encircled for preload reduction to obtain an
end-systolic PV relationship. A pacing lead for detection of ventricular
electrocardiography (ECG) was sutured on the anterior wall of the right
ventricle (Figure 1, A).
After these preparations, we waited for at least 30 minutes to ensure he-
modynamic stability. All experimental protocols were approved by the An-
imal Research Committee of the National Cerebral and Cardiovascular
Center Research Institute and conducted according to its veterinary
guidelines.
Experimental Protocol
During data collection, target preload was set at 10 mm Hg by mean
CVP, and we controlled the infusion volume to maintain this level. Target
heart rate and systolic pressure were 60 to 90 beats/min and 80 to 120 mm
Hg, respectively. If these parameters deviated from their targets, we ad-
justed the concentration of inhaled isoflurane. No vasopressive agents
were used. Lidocaine (1 mg/kg/h) was continuously infused to prevent ven-
tricular arrhythmias. We evaluated retrograde PF and LV workload under 3
conditions: 1) circuit clamp (no pump support), 2) continuous mode (con-
stant RPM), and 3) off-test mode (increasing RPM in diastole). RPM set-
tings for these modes are described in detail below. We waited 5 minutes
to obtain hemodynamic stability after setting up the drive mode. Pressure
and flow data were collected in Labchart5 (ADInstruments Pty Ltd, Bella
Vista, Australia). We analyzed PF waveforms. Negative PF was integrated
by time, and retrograde PF was calculated and shown as the amount per
minute. At completion of the experiments, the hearts were excised, and
the LV was weighed for weight normalization of MVO2 and PVA per
100 grams of LV tissue.
Drive Mode
In continuous mode, RPM was set to establish a mean PF of approxi-
mately 0 L/min. In off-test mode, we used the following novel ECG-
synchronized RPM change mode. Direct ECG detection from a ventricular
lead for synchronization in pulsatile LVADs was previously reported,15 but
direct ECG-synchronized RPM change for rotary LVADs is rare according
to our search of the literature, and we are currently developing various clin-
ical applications for this system.16,17
The details of our novel pump controller have been reported.13 Briefly,
the controller can detect R waves from the ventricular ECG and instantly
increase RPM to the target speed after configuration of the delay time
from the R wave. The primary goal of our off-test mode is achieving
both minimal systolic support and prevention of diastolic retrograde PF.
Therefore in off-test mode, systolic RPM was set at 700, which is the min-
imum RPM of the current system, and diastolic RPM was set to ensure di-
astolic PF near 0 L/min. We adjusted this diastolic RPM manually while
monitoring the PF curve. The time that the target speed is maintained
can also be configured. We defined the systolic phase as 33% of the RR in-
terval and the diastolic phase as the remaining 67%. Thus, in off-test mode,
delay time was set as the systolic phase, or 33% of the RR interval. For ex-
ample, at a native heart rate of 90 beats/min, the RR interval is 670 msec,
with 33% being 220 msec. Pumps were thus driven at a systolic RPM of
700 from the R-wave input for 220 msec, and diastolic RPM was instantly
increased to achieve a diastolic PF of approximately 0 L/min. We main-
tained this diastolic RPM for the other 67% of the RR interval, or 450
msec, and finally returned to the initial systolic RPM of 700 rpm. We cal-
culated the bypass rate by dividing PF by the sum of PF and AoF, as shown
in ‘‘Results.’’diovascular Surgery c Volume 143, Number 5 1177
FIGURE 1. A, Experimental settings. B, PV loop. PVA is the sum of external work and potential energy. LMT, Left main trunk (of the coronary artery);
IVC, inferior vena cava; ECG, electrocardiogram; ESPVR, end-systolic pressure volume relationship; LV, left ventricular; EW, external work; PE, potential
energy; PVA, pressure volume area; EDPVR, end-diastolic pressure volume relationship; V0, X axis intercept of the end-systolic PV relationship slope.
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We calculated MVO2 for evaluation of LV workload.16,18-20 A 10F
retrograde cardioplegic catheter (Gandry RCSP catheter, 94110,
Medtronic Japan Co, Ltd, Tokyo, Japan) was inserted into the coronary
sinus through the hemiazygos vein. A balloon was inflated, and coronary
vein blood was drawn via a small hole created manually just before
a balloon to avoid collecting mixed central venous blood.18 We calculated
MVO2 by the following formula: MVO2 (O2 mL/min) ¼ {(ScaO2 
ScvO2) $ 1.34 $ aHb þ (PcaO2  PcvO2) $ 0.003} $ 0.01 $ coronary
flow, where ScaO2 (ScvO2) is the oxygen saturation of coronary artery
(vein) blood, PcaO2 (PcvO2), mm Hg is the partial pressure of coronary
artery (vein) blood, and aHb, g/dL is the hemoglobin concentration of cor-
onary artery blood.
We calculated normalized MVO2 per beat per 100 g of LV tissue. Data
are presented as percentages of those in the circuit clamp, taken as 100%.
Pressure Volume Area Assessment
The Sigma5 DF system (CD Leycom, Zoetermeer, The Netherlands)
was used for PV loop analysis. The end-systolic PV relationship slope
was obtained by gradually occluding the inferior vena cava. PVA, recog-
nized as a measure of total mechanical energy,19,20 was approximated
using a previously established method.20,21 Briefly, external work is
a computed area in the loop and potential energy is a crescent-shaped
area between the end-systolic PV relationship slope and isovolumic relax-
ation (Figure 1, B). PVA, the sum of external work and potential energy, is
shown as the normalized value per 100 g of LV tissue.20 We also evaluated
end-systolic pressure, end-systolic volume (ESV), end-diastolic pressure
(EDP), and end-diastolic volume (EDV). We drew blood and performed
calibration with a conductivity meter. However, the absolute LV volume
value does not reflect actual LV volume. Therefore, we evaluated these
data by comparative assessment with LV volume under circuit-clamp con-
ditions as the baseline (100%). LV pressure data are also presented as per-
cent values.
Statistical Analysis
All numeric data are shown as average  standard deviation. Compar-
isons between groups were performed by repeated-measures analysis of
variance followed by Tukey’s multiple comparison test. All analyses
were conducted using a 2-sided method. The efficacy outcome measure
was the retrograde PF amount. We specified a minimum detectable differ-
ence in retrograde PF of 0.75 L/min (the difference between a mean of 1.40
L/min for continuous mode and 0.65 L/min for off-test mode). Therefore,1178 The Journal of Thoracic and Cardiovascular Sura sample size of 8 was selected to ensure 80% power for detecting the spec-
ified minimum difference at a 2-sided significance level of .05. We used
PASWStatistics18 (IBM SPSS Inc, Chicago, Ill) for all statistical analyses.RESULTS
Figure 2 shows sample waveforms of pressure and flow
data. In continuous mode, diastolic reverse PF was observed
and diastolic AoP shifted upward compared with the circuit
clamp (Figure 2). While in off-test mode, diastolic RPM
was increased by synchronization and the reversal of PF al-
most completely disappeared. Diastolic AoP was main-
tained in off-test mode.
Table 1 shows numeric flow and pressure data. There was
no significant change in heart rate, mean CVP, mean AoP, or
mean LV pressure. In continuous mode, RPM was approx-
imately 990 and PF was 0.19 L/min (Table 1). In off-test
mode, systolic RPM was 690 and diastolic RPM was
1320. PF increased to 0.66 from 0.19 L/min in continuous
mode, but the difference was not significant. In off-test
mode, AoF was significantly decreased and the bypass
rate was significantly increased compared with continuous
mode (Table 1).
PV loops are shown in Figure 3. In continuous mode,
both end-systolic and diastolic points were shifted right-
ward compared with the circuit-clamp. End-diastolic points
also shifted upward. While in off-test mode, the loop was
similar to that under circuit-clamp conditions. Ventricular
pressures and volumes are shown in Figure 4. In continuous
mode,%EDP was increased (P ¼ .001).%EDP decreased
in off-test mode, but the difference was not significant
(P¼ .08). Both%EDVand%ESV increased in continuous
mode, but these differences also did not reach statistical
significance.
%PVA and %MVO2 in each mode are shown in
Figure 5, A.%PVA increased in continuous mode, but the
difference was not significant. In off-test mode, %PVAgery c May 2012
FIGURE 2. Pressure and flow waveforms. In continuous mode, diastolic reverse PF was observed. However in off-test mode, diastolic RPM increased and
the reversal of PF disappeared completely. ECG, Electrocardiogram; AoP, aortic pressure; CVP, central venous pressure; LVP, left ventricular pressure; PF,
pump flow; AoF, ascending aortic flow; CoF, coronary flow; RPM, revolution per minute.
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der circuit-clamp conditions. The amount of retrograde PF
in each mode is shown in Figure 5, B. In continuous mode,
the amount was 1.38  0.62 L/min, and significantly de-
creased to 0.66  0.57 L/min (P ¼ .005) in off-test mode.
DISCUSSION
Our ultimate goal is to establish a safe and appropriate
weaning protocol for rotary LVAD removal. Our novel drive
mode that can change pump RPM via synchronization suc-
cessfully reduced the amount of retrograde PF in diastole
during pump weaning while keeping LV workload similar
to that under circuit-clamp conditions. These data raiseTABLE 1. Flow and pressure data
Mode
Circuit
clamp
Continuous
mode Off-test mode
Heart rate (rpm) 78.0  13.8 77.9  13.5 75.6  13.9
Mean CVP (mm Hg) 11.8  5.3 11.7  4.9 12.3  4.6
Mean AoP (mm Hg) 62.4  11.2 56.3  8.8 57.1  12.4
Mean LVP (mm Hg) 38.9  11.7 38.9  11.4 37.5  10.7
Systolic RPM 0.0  0.0 990  210* 690  60*,y
Diastolic RPM 0.0  0.0 990  210* 1320  290*,y
Mean RPM 0.0  0.0 960  190* 1060  210*
PF (L/min) 0.00  0.00 0.19  0.37 0.66  0.85
AoF (L/min) 3.94  1.93 3.68  1.89 2.75  1.32*,y
Bypass rate (%) 0.0  0.0 5.7  10.6 19.5  14.5*,y
LVP, Left ventricular pressure. *Significant change from circuit-clamp condition.
ySignificant change from continuous mode.
The Journal of Thoracic and Carthe possibility of mimicking circuit-clamp conditions while
evaluating native heart function before LVAD removal,
even in rotary LVADs implanted intracorporeally. These
findings are both unique and clinically relevant.
In addition to the weaning protocol, other factors, such as
patient selection and effective adjunctive therapies, are
clearly of great significance. Dandel and colleagues4 re-
ported pre-explantation factors, including duration of
LVAD support, heart failure duration before LVAD implan-
tation, and echocardiographic findings, to predict cardiac
stability after LVAD removal. Birks and colleagues3,9
have suggested the importance of medical therapy,
including the beta-2 agonist clenbuterol in combination
with mechanical support.3,9 Other medical therapies,22 re-
synchronization therapy,23 or rehabilitation23 during VAD
support augment the rate of successful removal. In the
near future, even molecular changes occurring during re-
verse remodeling might be of value in assessing device
withdrawal.24 Nevertheless, creating or mimicking no-
support circumstances before removal would likely still
be necessary.
Figure 2 shows sample pressure and waveforms. In con-
tinuous mode, retrograde PF persisted and diastolic AoP
was shifted downward, possibly because of this retrograde
PF. In off-test mode, the amount of retrograde PF decreased
as diastolic RPM increased, and diastolic AoP was similar
to that under circuit-clamp condition. Comparing PF wave
forms between continuous and off-test modes showeddiovascular Surgery c Volume 143, Number 5 1179
FIGURE 3. PV loops. End-systolic point (black dot) and end-diastolic point (white circle). In continuous mode, end-systolic and end-diastolic points are
shifted rightward compared with circuit-clamp conditions. End-diastolic points are shifted upward. In off-test mode, the loop is similar to that in circuit-
clamp condition.
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flow,’’ meaning certain amounts of both forward and back-
ward flow persisted. While in off-test mode, an almost flat
PF waveform was obtained, and this mode showed ‘‘zero-
total-flow in the circuit,’’ as if the circuit was clamped.
This was the PF waveform we were endeavoring to achieve
in the current study (Figure 2).FIGURE 4. LV pressure and volume data. These parameters are shown as perce
was significantly increased in continuous mode compared with circuit-clamp co
diastolic pressure; EDV, end-diastolic volume.
1180 The Journal of Thoracic and Cardiovascular SurThe coronary flow waveform in off-test mode was sim-
ilar to that under circuit-clamp conditions, whereas that in
continuous mode was entirely different from those in the
other 2 states, in that diastolic coronary flow was de-
creased (Figure 2). We speculate that in continuous
mode, LVED pressure was increased because of retro-
grade PF (Figure 4), and diastolic coronary flow couldntages of values under circuit-clamp conditions as baseline (100%).%EDP
nditions. ESP, End-systolic pressure; ESV, end-systolic volume; EDP, end-
gery c May 2012
FIGURE 5. A, PVA and MVO2. There were no significant changes in PVA or MVO2 in any of the 3 modes. B, Retrograde PF. In continuous mode, the
amount of reverse PF was 1.38 L/min. However, this was significantly decreased to 0.66 L/min in off-test mode. PVA, Pressure volume area;MVO2, myo-
cardial oxygen consumption.
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pressure.19,25
Table 1 shows flow and pressure numeric data. There
were no changes in heart rate, CVP, AoP, or LV pressure.
In off-test mode, PF was increased compared with continu-
ous mode. This change, attributed to reduced retrograde PF,
was not significant. In off-test mode, AoF was significantly
decreased (Table 1). This AoF decrease may have also been
due to reduced retrograde PF. The present study used a nor-
mal heart model, such that in continuous mode the native
heart could compensate for backward flow by increasing
AoF. This compensation could represent an excessive load
on the native heart during pump weaning. While in off-
test mode, there was almost no reverse flow, making com-
pensation by the native heart unnecessary. In the systolic
phase, it would be natural for a small amount of forward
flow to occur in off-test mode (Figure 2), because the
pump circuit is open. We believe this systolic forward
flow was ejected mostly by the native heart because systolic
RPM in off-test mode was set at 700, the minimum RPM in
the current system (Table 1).
Figure 3 shows sample PV loops, and Figure 5, A, shows
changes in%PVA and%MVO2.Wewere successful in ob-
taining similar PV loops in off-test mode and circuit-clamp
states, meaning that the native heart workload was almost
the same in these 2 settings (Figure 5, A). In continuous
mode, the PV loop was larger than under the other 2 condi-
tions, but this change was not significant. We speculate that
the lack of significant change in LV workload is attributable
to good ventricular function. The results would have been
different had we conducted the same investigation in a heart
failure model. Figure 4 shows LV pressure and volume. In
continuous mode, EDP was significantly increased com-
pared with circuit-clamp conditions (P ¼ .001), and off-
test mode blunted this elevation in EDP (P ¼ .08). EDV
and ESV were unchanged, possibly because of lowThe Journal of Thoracic and Carcompliance of the native heart and the rate of LV volume
change. In continuous mode, EDP occasionally doubled,
for example, from 10 to 20 mm Hg, but there was no in-
crease in EDV or ESV even with such a large change.
Figure 5, B, shows changes in retrograde PF, indicating
off-test mode to successfully reduce retrograde PF. The ret-
rograde PF difference between the 2 modes was modest, but
this difference might be larger in heart failure models, pos-
sibly affecting native heart recovery.
There have been clinical reports describing pump-off tri-
als after myocardial recovery.3,4,8,11 In patients with
pulsatile pumps, Mano and colleagues8 conducted dobut-
amine stress testing under minimal support with pulsatile
LVADs, driven at 60 beats/min. Dandel and colleagues4 per-
formed 10-minute echocardiography under support at 1
beat/min, which necessitated systemic heparinization.
With most pulsatile LVADs, there is little concern about ret-
rograde PF because of the mechanical valves in circuits, and
with commonly used pulsatile pumps, such as the Heart-
mate XVE (Thoratec Corp, Pleasanton, Calif), pump-off tri-
als can be attempted using intermittent hand pumping with
systemic anticoagulation. However, these trials should be
done relatively quickly to avoid intracircuit clotting. With
rotary LVADs, attempts have been made to adjust pump
RPM to achieve ‘‘zero net flow’’ condition, tolerating
both forward and backward flows in the circuit.4 However,
this approach to pump weaning raises concerns, because
retrograde PF in diastole might overload the native heart
and even be misleading for cardiac evaluation.10 As shown
in the current study, continuous mode with low RPM actu-
ally created a certain amount of retrograde PF (Figure 2),
and our off-test mode blunted this retrograde PF.
Even in the current era, weaning tests should be done on
admission under careful monitoring with a pulmonary ar-
tery catheter and echocardiography, relatively quickly be-
cause of the aforementioned retrograde PF duringdiovascular Surgery c Volume 143, Number 5 1181
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flow in a normal heart model. Before the clinical application
of this system, we must clarify its utility in heart failure
models. In the near future, it should be possible to more
safely maintain this mode for a relatively long time, even
a few months. Our ultimate goal is establish a safe and ap-
propriate weaning protocol for LVAD withdrawal that can
be carried out in the outpatient setting. The aims of an
off-test trial in the outpatient clinic would be (1) to allow
more time to safely decide on withdrawal, with careful pa-
tient selection; (2) to take into account patients’ activities of
daily living and symptoms in their own daily lives before
pump removal; and (3) to develop a reversible mode allow-
ing a return to full support conditions in the event of wors-
ening patient status.
Study Limitations
The present study has several limitations. First, we need
to establish the method of actual adjustment of diastolic
RPM in the clinical setting. With the current system, PF
monitoring during pump support is difficult. In practice,
we were able to measure the amount of retrograde PF by
echocardiography in the outpatient clinic, allowing diastolic
RPM to be adjusted. Second, our mode might result in stag-
nant flow within the circuit. Therefore, we must provide ad-
equate anticoagulation with Coumadin (Bristol-Myers
Squibb, Princeton, NJ) while using the off-test mode. Other-
wise, intracircuit stagnant flow might be washed out by in-
termittently increasing RPM. A study for evaluating
chronic thrombus formation is currently ongoing. Third,
the study was conducted using a normal heart model and
a relatively small sample number of animals. We will next
focus on a heart failure model, in which the native heart can-
not compensate for retrograde PF in continuous mode, such
that PVA and MVO2 will increase more than in the present
study. Further investigations will examine chronic heart fail-
ure models and include larger sample sizes, providing more
information on clotting or device durability.
CONCLUSIONS
Our newly developed off-test mode for centrifugal
LVADs can decrease retrograde PF during pump weaning
while keeping LV workload similar to that under circuit-
clamp conditions. This mode is of potential value in estab-
lishing a safe and appropriate LVAD weaning protocol after
myocardial recovery. Further investigation in chronic heart
failure models is currently ongoing.
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